Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9848)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2014 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Valenti L, Fracanzani AL, Dongiovanni P, Rovida S, Rametta R, Fatta E, Pulixi EA, Maggioni M, Fargion S. A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia. World J Gastroenterol 2014; 20(11): 3002-3010 [PMID: 24659891 DOI: 10.3748/wjg.v20.i11.3002] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i11/3002.htm |
| Number | Citing Articles |
| 1 |
Naomichi Abe, Takuma Tsuchida, Shin-Ichiro Yasuda, Kozo Oka. Dietary iron restriction leads to a reduction in hepatic fibrosis in a rat model of non-alcoholic steatohepatitis. Biology Open 2019; 8(5) doi: 10.1242/bio.040519
|
| 2 |
Calogero Vetro, Rosamaria Rosso, Stefano Palmucci, Maurizio Russello, Grazia Colletta, Maria Anna Romeo, Benedetta Ximenes, Alessandra Romano, Giuseppe Alberto Palumbo, Francesco Di Raimondo. Erythrocytapheresis is a valid and safe therapeutic option in dysmetabolic iron overload syndrome. Journal of Clinical Apheresis 2016; 31(5): 443 doi: 10.1002/jca.21434
|
| 3 |
Jun-Wei Wang, Chun-Hua Jin, Jiang-Feng Ke, Yi-Lin Ma, Yu-Jie Wang, Jun-Xi Lu, Mei-Fang Li, Lian-Xi Li. Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.942412
|
| 4 |
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Journal of Hepatology 2016; 64(6): 1388 doi: 10.1016/j.jhep.2015.11.004
|
| 5 |
Michael Doulberis, Georgios Kotronis, Dimitra Gialamprinou, Jannis Kountouras, Panagiotis Katsinelos. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. Metabolism 2017; 71: 182 doi: 10.1016/j.metabol.2017.03.013
|
| 6 |
Mohsen Arabi, Raheleh Alimoradzadeh, Alireza Makian, Seyed Javad Shariat Nabavi, Farshad Divsalar, Mitra Kazemi Jahromi. Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery, Based on Guideline Updates: A Mini Review. Journal of Health Reports and Technology 2022; 8(3) doi: 10.5812/jhrt-119454
|
| 7 |
James C. Barton, J. Clayborn Barton, Luigi F. Bertoli, Thomas J. Alford, Corwin Q. Edwards. Hepatic Iron in African Americans Who Underwent Liver Biopsy. The American Journal of the Medical Sciences 2015; 349(1): 50 doi: 10.1097/MAJ.0000000000000389
|
| 8 |
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease. Obesity Facts 2016; 9(2): 65 doi: 10.1159/000443344
|
| 9 |
Driton Vela. Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker. Molecular Medicine 2018; 24(1) doi: 10.1186/s10020-018-0008-7
|
| 10 |
Arvind R. Murali, Ashutosh Gupta, Kyle Brown. Systematic review and meta‐analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non‐alcoholic fatty liver disease. Hepatology Research 2018; 48(3) doi: 10.1111/hepr.12921
|
| 11 |
Katarzyna Sikorska, Agnieszka Bernat, Anna Wróblewska. Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis. Hepatobiliary & Pancreatic Diseases International 2016; 15(5): 461 doi: 10.1016/S1499-3872(16)60135-2
|
| 12 |
C. Corey Hardin, John K. Olynyk, Grant A. Ramm. Hemochromatosis. New England Journal of Medicine 2022; 387(23): 2159 doi: 10.1056/NEJMra2119758
|
| 13 |
Sarvesh Kumar Singh, Kshipra Rajoria. Medical leech therapy in Ayurveda and biomedicine – A review. Journal of Ayurveda and Integrative Medicine 2020; 11(4): 554 doi: 10.1016/j.jaim.2018.09.003
|
| 14 |
Clémence Rives, Anne Fougerat, Sandrine Ellero-Simatos, Nicolas Loiseau, Hervé Guillou, Laurence Gamet-Payrastre, Walter Wahli. Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants. Biomolecules 2020; 10(12): 1702 doi: 10.3390/biom10121702
|
| 15 |
Roman Huber. Integrative Behandlungsansätze bei chronischen Lebererkrankungen. Zeitschrift für Komplementärmedizin 2021; 13(02): 14 doi: 10.1055/a-1409-1992
|
| 16 |
Yongqing Zhou, Chuanchen Wu, Xin Wang, Ping Li, Nannan Fan, Wei Zhang, Zhenzhen Liu, Wen Zhang, Bo Tang. Exploring the Changes of Peroxisomal Polarity in the Liver of Mice with Nonalcoholic Fatty Liver Disease. Analytical Chemistry 2021; 93(27): 9609 doi: 10.1021/acs.analchem.1c01776
|
| 17 |
Simona Marchisello, Antonino Di Pino, Roberto Scicali, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Rabuazzo. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. International Journal of Molecular Sciences 2019; 20(8): 1948 doi: 10.3390/ijms20081948
|
| 18 |
Sandra Milic, Ivana Mikolasevic, Lidija Orlic, Edita Devcic, Nada Starcevic-Cizmarevic, Davor Stimac, Miljenko Kapovic, Smiljana Ristic. The Role of Iron and Iron Overload in Chronic Liver Disease. Medical Science Monitor 2016; 22: 2144 doi: 10.12659/MSM.896494
|
| 19 |
Gregory Thomas Brown, David E. Kleiner. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Metabolism 2016; 65(8): 1080 doi: 10.1016/j.metabol.2015.11.008
|
| 20 |
Priya Handa, Sunil Thomas, Vicki Morgan-Stevenson, Bryan D Maliken, Eric Gochanour, Sarag Boukhar, Matthew M Yeh, Kris V Kowdley. Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis. Journal of Leukocyte Biology 2019; 105(5): 1015 doi: 10.1002/JLB.3A0318-108R
|
| 21 |
Xian-E. Peng, Shang-Hua Xu, Wenjuan Liu, Zhijian Hu, Zheng Lin, Xu Lin. Independent and combined effects of dietary iron composition and selected risk factors on the risk of NAFLD in a Chinese population. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-40449-1
|
| 22 |
Xin Su, Danping Zhang, Zhe Chen, Xu Han, Peichen Xia, Minhao Yin, Hong Zhu. Associations between Abnormal Iron Metabolism and Elevated Alanine Aminotransferase in Adults. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4167832
|
| 23 |
Koji Miyanishi, Toshifumi Hoki, Shingo Tanaka, Junji Kato. Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy. World Journal of Hepatology 2015; 7(3): 593-599 doi: 10.4254/wjh.v7.i3.593
|
| 24 |
Caroline Willmann, Martin Heni, Katarzyna Linder, Robert Wagner, Norbert Stefan, Jürgen Machann, Matthias B Schulze, Hans-Georg Joost, Hans-Ulrich Häring, Andreas Fritsche. Potential effects of reduced red meat compared with increased fiber intake on glucose metabolism and liver fat content: a randomized and controlled dietary intervention study. The American Journal of Clinical Nutrition 2019; 109(2): 288 doi: 10.1093/ajcn/nqy307
|
| 25 |
María Pilar Vaquero, Ángel García-Quismondo, Francisco J. del Cañizo, Francisco J. Sánchez-Muniz. Recent Trends in Cardiovascular Risks. 2017; doi: 10.5772/intechopen.69040
|
| 26 |
Monique Fernandez, Julie Lokan, Christopher Leung, Andrew Grigg. A critical evaluation of the role of iron overload in fatty liver disease. Journal of Gastroenterology and Hepatology 2022; 37(10): 1873 doi: 10.1111/jgh.15971
|
| 27 |
Shweta S. Namjoshi, Cristina Farkas, Nicholas J. Jackson, Laurie E. Reyen, Pamela S. Baldivia, Jorge H. Vargas, Robert S. Venick, Patricia L. Weng, Mark R. Hanudel, Tomas Ganz, Laura J. Wozniak. Anemia of Inflammation in Patients with Intestinal Failure on Home Parenteral Nutrition. SN Comprehensive Clinical Medicine 2020; 2(9): 1505 doi: 10.1007/s42399-020-00404-y
|
| 28 |
Stergios Kechagias, Patrik Nasr, Julia Blomdahl, Mattias Ekstedt. Established and emerging factors affecting the progression of nonalcoholic fatty liver disease. Metabolism 2020; 111: 154183 doi: 10.1016/j.metabol.2020.154183
|
| 29 |
Jeremy Gillespie. “You Are What You Eat”: The Role of Dietary Macronutrients and Micronutrients in MAFLD. Clinical Liver Disease 2021; 18(2): 67 doi: 10.1002/cld.1083
|
| 30 |
Machi Atarashi, Takeshi Izawa, Rena Miyagi, Shoko Ohji, Ai Hashimoto, Mitsuru Kuwamura, Jyoji Yamate. Dietary Iron Supplementation Alters Hepatic Inflammation in a Rat Model of Nonalcoholic Steatohepatitis. Nutrients 2018; 10(2): 175 doi: 10.3390/nu10020175
|
| 31 |
Sebastian K. Eder, Alexandra Feldman, Georg Strebinger, Jana Kemnitz, Stephan Zandanell, David Niederseer, Michael Strasser, Heike Haufe, Karl Sotlar, Felix Stickel, Bernhard Paulweber, Christian Datz, Elmar Aigner. Mesenchymal iron deposition is associated with adverse long‐term outcome in non‐alcoholic fatty liver disease. Liver International 2020; 40(8): 1872 doi: 10.1111/liv.14503
|
| 32 |
Ma Ai Thanda Han, Osama Altayar, Shadi Hamdeh, Varun Takyar, Yaron Rotman, Ohad Etzion, Eric Lefebvre, Rifaat Safadi, Vlad Ratziu, Larry J. Prokop, Mohammad Hassan Murad, Mazen Noureddin. Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2019; 17(4): 616 doi: 10.1016/j.cgh.2018.06.011
|
| 33 |
Érica Martins Ferreira Gotardo, Cintia Rabelo e Paiva Caria, Caroline Candida de Oliveira, Thalita Rocha, Marcelo Lima Ribeiro, Alessandra Gambero. Effects of iron supplementation in mice with hypoferremia induced by obesity. Experimental Biology and Medicine 2016; 241(18): 2049 doi: 10.1177/1535370216660398
|
| 34 |
|
| 35 |
Lipika Salaye, Ielizaveta Bychkova, Sandy Sink, Alexander J. Kovalic, Manish S. Bharadwaj, Felipe Lorenzo, Shalini Jain, Alexandria V. Harrison, Ashley T. Davis, Katherine Turnbull, Nuwan T. Meegalla, Soh-hyun Lee, Robert Cooksey, George L. Donati, Kylie Kavanagh, Herbert L. Bonkovsky, Donald A. McClain. A Low Iron Diet Protects from Steatohepatitis in a Mouse Model. Nutrients 2019; 11(9): 2172 doi: 10.3390/nu11092172
|
| 36 |
Fabrice Lainé, Marc Ruivard, Véronique Loustaud‐Ratti, Fabrice Bonnet, Paul Calès, Edouard Bardou‐Jacquet, Sylvie Sacher‐Huvelin, Xavier Causse, Christine Beusnel, Alain Renault, Eric Bellissant, Yves Deugnier. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients. Hepatology 2017; 65(2): 465 doi: 10.1002/hep.28856
|
| 37 |
Yves Deugnier, Édouard Bardou-Jacquet, Fabrice Lainé. Dysmetabolic iron overload syndrome (DIOS). La Presse Médicale 2017; 46(12): e306 doi: 10.1016/j.lpm.2017.05.036
|
| 38 |
Serena Pelusi, Salvatore Petta, Chiara Rosso, Vittorio Borroni, Anna Ludovica Fracanzani, Paola Dongiovanni, Antonio Craxi, Elisabetta Bugianesi, Silvia Fargion, Luca Valenti, Vincent Wong. Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease. PLOS ONE 2016; 11(9): e0163069 doi: 10.1371/journal.pone.0163069
|
| 39 |
Takashi Himoto, Koji Fujita, Shima Mimura, Joji Tani, Asashiro Morishita, Satoru Kubota, Tsutomu Masaki. Involvement of essential trace elements in the pathogenesis of hepatitis C virus‑related chronic liver disease and nonalcoholic steatohepatitis. Experimental and Therapeutic Medicine 2023; 27(1) doi: 10.3892/etm.2023.12307
|
| 40 |
Octavia Pickett-Blakely, Kimberly Young, Rotonya M. Carr. Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis. Cellular and Molecular Gastroenterology and Hepatology 2018; 6(4): 451 doi: 10.1016/j.jcmgh.2018.07.004
|
| 41 |
Sherif S. Shabana, Hany H. Kaisar, Hany A. Hussein, Mohammed M. Abdel-Hakim. Assessment of serum hepcidin level and iron profile in obese patients with nonalcoholic fatty liver disease. Egyptian Liver Journal 2018; 8(2): 55 doi: 10.1097/01.ELX.0000544521.92145.3f
|
| 42 |
Takashi Himoto, Tsutomu Masaki. Current Trends of Essential Trace Elements in Patients with Chronic Liver Diseases. Nutrients 2020; 12(7): 2084 doi: 10.3390/nu12072084
|
| 43 |
Kosha J Mehta, Sebastien Je Farnaud, Paul A Sharp. Iron and liver fibrosis: Mechanistic and clinical aspects. World Journal of Gastroenterology 2019; 25(5): 521-538 doi: 10.3748/wjg.v25.i5.521
|
| 44 |
Laurence J Britton, V Nathan Subramaniam, Darrell HG Crawford. Iron and non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(36): 8112-8122 doi: 10.3748/wjg.v22.i36.8112
|
| 45 |
Carine Fillebeen, Nhat Hung Lam, Samantha Chow, Amy Botta, Gary Sweeney, Kostas Pantopoulos. Regulatory Connections between Iron and Glucose Metabolism. International Journal of Molecular Sciences 2020; 21(20): 7773 doi: 10.3390/ijms21207773
|
| 46 |
Tyler J Severson, Siddesh Besur, Herbert L Bonkovsky. Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review. World Journal of Gastroenterology 2016; 22(29): 6742-6756 doi: 10.3748/wjg.v22.i29.6742
|
| 47 |
Luca Valenti. Uncovering the genetics of cirrhosis: New plots for the usual suspects. Liver International 2020; 40(2): 281 doi: 10.1111/liv.14333
|
| 48 |
Afshan Syed Abbas, Tasleem Akhtar, Najma Shaheen, Sumaira Aslam, Nadeem Sheikh. Mechanistic study of regulation of iron homeostasis by N. sativa seeds and P. ovata husks on high fat/high sucrose diet induced non-alcoholic fatty liver disease. Molecular Biology Reports 2022; 49(8): 7417 doi: 10.1007/s11033-022-07538-3
|
| 49 |
J.L. Martin-Rodriguez, J. Gonzalez-Cantero, A. Gonzalez-Cantero, L. Martí-Bonmatí, Á. Alberich-Bayarri, T. Gonzalez-Cejudo, J.L. Gonzalez-Calvin. Insulin resistance and NAFLD: Relationship with intrahepatic iron and serum TNF-α using 1H MR spectroscopy and MRI. Diabetes & Metabolism 2019; 45(5): 473 doi: 10.1016/j.diabet.2019.01.005
|
| 50 |
Elena Corradini, Elena Buzzetti, Paola Dongiovanni, Stefania Scarlini, Angela Caleffi, Serena Pelusi, Isabella Bernardis, Paolo Ventura, Raffaela Rametta, Elena Tenedini, Enrico Tagliafico, Anna Ludovica Fracanzani, Silvia Fargion, Antonello Pietrangelo, Luca Vittorio Valenti. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD. Journal of Hepatology 2021; 75(3): 506 doi: 10.1016/j.jhep.2021.03.014
|
| 51 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Iron as a therapeutic target in chronic liver disease. World Journal of Gastroenterology 2023; 29(4): 616-655 doi: 10.3748/wjg.v29.i4.616
|
| 52 |
Elmar Aigner, Günter Weiss, Christian Datz. Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver. World Journal of Hepatology 2015; 7(2): 177-188 doi: 10.4254/wjh.v7.i2.177
|
| 53 |
Irwin K. Cheah, Richard Tang, Peng Ye, Terry S. Z. Yew, Keith H. C. Lim, Barry Halliwell. Liver ergothioneine accumulation in a guinea pig model of non-alcoholic fatty liver disease. A possible mechanism of defence?. Free Radical Research 2016; 50(1): 14 doi: 10.3109/10715762.2015.1099642
|
| 54 |
Heinz Zoller, Herbert Tilg. Ferritin—a promising biomarker in MASLD. Gut 2024; 73(5): 720 doi: 10.1136/gutjnl-2023-331848
|
| 55 |
Wen-Yue Liu, Li-You Lian, Huai Zhang, Sui-Dan Chen, Xin-Zhe Jin, Ni Zhang, Chen-Hui Ye, Wen-Ying Chen, George Goh Boon Bee, Fu-Di Wang, Luca Miele, Elena Corradini, Luca Valenti, Ming-Hua Zheng. A Population-Based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic Hyperferritinemia. The Journal of Clinical Endocrinology & Metabolism 2024; 109(6): 1540 doi: 10.1210/clinem/dgad749
|
| 56 |
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang, Joo Sung Kim. Associations between hemoglobin concentrations and the development of incidental metabolic syndrome or nonalcoholic fatty liver disease. Digestive and Liver Disease 2017; 49(1): 57 doi: 10.1016/j.dld.2016.10.004
|
| 57 |
Kexin Sun, Jie V. Zhao, Edmund Anthony Severn Nelson, Vincent Wai Sun Wong, Hugh Simon Hung San Lam, Lai Ling Hui. Iron status and non-alcoholic fatty liver disease: A Mendelian randomization study. Nutrition 2024; 118: 112295 doi: 10.1016/j.nut.2023.112295
|
| 58 |
Luca Valenti, Elena Corradini, Leon A. Adams, Elmar Aigner, Saleh Alqahtani, Marco Arrese, Edouard Bardou-Jacquet, Elisabetta Bugianesi, Jose-Manuel Fernandez-Real, Domenico Girelli, Hannes Hagström, Benjamin Henninger, Kris Kowdley, Guido Ligabue, Donald McClain, Fabrice Lainé, Koji Miyanishi, Martina U. Muckenthaler, Alessia Pagani, Patrizia Pedrotti, Antonello Pietrangelo, Daniele Prati, John D. Ryan, Laura Silvestri, C. Wendy Spearman, Per Stål, Emmanuel A. Tsochatzis, Francesca Vinchi, Ming-Hua Zheng, Heinz Zoller. Consensus Statement on the definition and classification of metabolic hyperferritinaemia. Nature Reviews Endocrinology 2023; 19(5): 299 doi: 10.1038/s41574-023-00807-6
|
| 59 |
Agustin Castiella, Iratxe Urreta, Eva Zapata, Leire Zubiaurre, Jose M. Alústiza, Pedro Otazua, Emma Salvador, Garazi Letamendi, Beatriz Arrizabalaga, Maria L. Rincón, José I. Emparanza. Liver iron concentration in dysmetabolic hyperferritinemia: Results from a prospective cohort of 276 patients. Annals of Hepatology 2020; 19(1): 31 doi: 10.1016/j.aohep.2019.07.014
|
| 60 |
Gerald Koenig, Stephanie Seneff. Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/818570
|
| 61 |
Aalam Sohal, Hunza Chaudhry, Kris V. Kowdley. Genetic Markers Predisposing to Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2023; 27(2): 333 doi: 10.1016/j.cld.2023.01.006
|
| 62 |
Raffaelle K Barros, Helma Pinchemel Cotrim, Carla H Daltro, Yanaihara A Oliveira. Hyperferritinemia in patients with nonalcoholic fatty liver disease. Revista da Associação Médica Brasileira 2017; 63(3): 284 doi: 10.1590/1806-9282.63.03.284
|
| 63 |
Koji Miyanishi, Shingo Tanaka, Hiroki Sakamoto, Junji Kato. The role of iron in hepatic inflammation and hepatocellular carcinoma. Free Radical Biology and Medicine 2019; 133: 200 doi: 10.1016/j.freeradbiomed.2018.07.006
|
| 64 |
Sakura Fujiwara, Takeshi Izawa, Mutsuki Mori, Machi Atarashi, Jyoji Yamate, Mitsuru Kuwamura. Dietary iron overload enhances Western diet induced hepatic inflammation and alters lipid metabolism in rats sharing similarity with human DIOS. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-25838-3
|
| 65 |
Yuan Liu, Xiang Qin, Tianzhu Chen, Mengyao Chen, Liyan Wu, Beihui He. Exploring the interactions between metabolic dysfunction-associated fatty liver disease and micronutrients: from molecular mechanisms to clinical applications. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1344924
|
| 66 |
Leon A. Adams, Darrell H. Crawford, Katherine Stuart, Michael J. House, Timothy G. St. Pierre, Malcolm Webb, Helena L.I. Ching, Jenny Kava, Michael Bynevelt, Gerry C. MacQuillan, George Garas, Oyekoya T. Ayonrinde, Trevor A. Mori, Kevin D. Croft, Xianwa Niu, Gary P. Jeffrey, John K. Olynyk. The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial. Hepatology 2015; 61(5): 1555 doi: 10.1002/hep.27662
|
| 67 |
Stephen A. Harrison, Mark M. Pence, Amy N. Stratton, Dawn M. Torres. Zakim and Boyer's Hepatology. 2018; : 406 doi: 10.1016/B978-0-323-37591-7.00027-6
|
| 68 |
Raffaela Rametta, Paola Dongiovanni, Serena Pelusi, Paolo Francione, Federica Iuculano, Vittorio Borroni, Erika Fatta, Annalisa Castagna, Domenico Girelli, Silvia Fargion, Luca Valenti. Hepcidin resistance in dysmetabolic iron overload. Liver International 2016; 36(10): 1540 doi: 10.1111/liv.13124
|
| 69 |
Ahmad Hormati, Ali Khanyabi, Sajjad Ahmadpour, Faezeh Alemi, Seyed Saeid Sarkeshikian, Mahboubeh Afifian, Abolfazl Mohammadbeig, Mohammad Reza Ghadir. Outcome of Phlebotomy on Improvement of Liver Enzymes and Steatosis in Non-Alcoholic Fatty Liver Disease: A Randomized, Controlled Trial. Journal of Advances in Medical and Biomedical Research 2022; 30(143): 493 doi: 10.30699/jambs.30.143.493
|
| 70 |
Isabella Reccia, Jayant Kumar, Cherif Akladios, Francesco Virdis, Madhava Pai, Nagy Habib, Duncan Spalding. Non-alcoholic fatty liver disease: A sign of systemic disease. Metabolism 2017; 72: 94 doi: 10.1016/j.metabol.2017.04.011
|
| 71 |
Mariana Verdelho Machado, Anna Mae Diehl. Zakim and Boyer's Hepatology. 2018; : 369 doi: 10.1016/B978-0-323-37591-7.00025-2
|
| 72 |
Giuseppina Pisano, Rosa Lombardi, Anna Fracanzani. Vascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and Ferritin. International Journal of Molecular Sciences 2016; 17(5): 675 doi: 10.3390/ijms17050675
|
| 73 |
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia 2016; 59(6): 1121 doi: 10.1007/s00125-016-3902-y
|
| 74 |
Amy Botta, Nicole G. Barra, Nhat Hung Lam, Samantha Chow, Kostas Pantopoulos, Jonathan D. Schertzer, Gary Sweeney. Iron Reshapes the Gut Microbiome and Host Metabolism. Journal of Lipid and Atherosclerosis 2021; 10(2): 160 doi: 10.12997/jla.2021.10.2.160
|
| 75 |
Christine C. Hsu, Nizar H. Senussi, Kleber Y. Fertrin, Kris V. Kowdley. Iron overload disorders. Hepatology Communications 2022; 6(8): 1842 doi: 10.1002/hep4.2012
|
| 76 |
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Amedeo Lonardo. The independent predictors of non‐alcoholic steatohepatitis and its individual histological features.. Hepatology Research 2016; 46(11): 1074 doi: 10.1111/hepr.12656
|
| 77 |
Leilismara Sousa, Marina M. Oliveira, Marco Túlio C. Pessôa, Leandro A. Barbosa. Iron overload: Effects on cellular biochemistry. Clinica Chimica Acta 2020; 504: 180 doi: 10.1016/j.cca.2019.11.029
|